A Study of the Views of Women Who Have Uterine Fibroids and About New Reproductive Technologies and Their Potential Uses


About this study

The purpose of this study is:

  • To assess how women who have undergone treatment for UF view the experience, whether they prioritize experimental approaches to remedy any impacts on their fertility, and the psychosocial and socio-economic factors most important to them in considering the preservation or restoration of fertility.
  • To assess the potential perceptions or experiences of women of African descent compared with women of other ethnic backgrounds of disparities in the symptoms and how treatment options for UF may impact willingness or ability to pursue approaches to fertility maintenance and restoration.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Between 18 and 45 years of age 
  • Biologically female 
  • English-speaking 
  • US resident 
  • Has received a diagnosis/treatment for symptomatic uterine fibroids

Exclusion Criteria: 

  • Minor (under 18) or older than 45 
  • Not biologically female 
  • Non-English speaker 
  • Not US resident 
  • Has not received either a diagnosis or treatment for uterine fibroids


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Megan Allyse, Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer